TrademarkDir
XIRXON
LIVE

Serial Number

79233972

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 24, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

XIRXON Trademark

Serial Number: 79233972 • Registration: 6835695

XIRXON is a trademark filed by NOVARTIS AG on March 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 24, 2018

Registration Date

September 6, 2022

Published for Opposition

June 21, 2022

Cancellation Date

August 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 5, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 5, 2026 DETH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 1, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2022 CNSA
ASSIGNED TO EXAMINER
Apr 25, 2022 DOCK
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Apr 19, 2022 CREV
REG. CANCELLED - RESTORED TO PENDENCY
Feb 3, 2022 CRTP
ASSIGNED TO PETITION STAFF
Jan 24, 2022 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Jan 20, 2022 RCII
NOTIFICATION PROCESSED BY IB
Jul 26, 2019 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2019 FINP
IRREGULARITY FROM IB EXAMINED BY MPU
Mar 14, 2019 IRRH
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Mar 11, 2019 IRFI
GENERIC MADRID TRANSACTION SENT TO IB
Feb 22, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 22, 2019 XXCR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 14, 2019 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jan 23, 2019 ES7R
POST PUBLICATION AMENDMENT – NOT ENTERED
Jan 16, 2019 CHPN
ASSIGNED TO PETITION STAFF
Jan 15, 2019 APET
REGISTERED-PRINCIPAL REGISTER
Jan 15, 2019 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 21, 2018 EPPA
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 20, 2018 CRCV
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 19, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 19, 2018 REAP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 9, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 30, 2018 ETOF
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTICE OF PUBLICATION
Jul 11, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 7, 2018 SDRC

Related Trademarks

More from this Owner

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA

CALIHE

CALIHE